Verrica Pharmaceuticals Inc

Verrica Pharmaceuticals Inc

VRCA

Get informed when a big investor buys or sells

+ Follow
Market Cap$54.11M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Verrica Pharmaceuticals IncVerrica Pharmaceuticals Inc-2.3--724%4.90.7
$-4.80

Current Fair Value

198.7% downside

Overvalued by 198.7% based on the discounted cash flow analysis.

Share Statistics

Market cap$54.11 Million
Enterprise Value$46.06 Million
Dividend Yield$- (-)
Earnings per Share$-1.68
Beta1.48
Outstanding Shares21,305,025

Return

Return on Equity-724.01%ROE
Return on Assets-86.58%
Return on Invested Capital-205.09%

Valuation & Multiples

P/E Ratio-2.31P/E Ratio
PEG0.04PEG
Price to Sales4.86Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue1.52
Enterprise Value to EBIT-1.65
Enterprise Value to Net Income-2
Total Debt to Enterprise0.07
Debt to Equity0.73Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 11, 2026
EPS Estimate
$-0.41
Average shareholder expectation
Revenue Estimate
$5.73 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 13, 2026
EPS Estimate
$-0.42
Average shareholder expectation
Revenue Estimate
$6.40 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %44.85%▼ 3.93%
Total Invested$25.28M▼ 41.43%
Investors Holding39▼ 10.00%

ESG Score

No data

About Verrica Pharmaceuticals Inc

CEO: Ted White